tm logo
MED-OLIGO
ADVERTISED

on 30 Oct 2024

Last Applicant/ Owned by

AUSPER BIOPHARMA CO. LTD.

Room 2501, 25th Floor, Building 5, No. 688 Bin'an Road,Changhe Street, Binjiang District,Hangzhou City, Zhejiang Province, 310000

CN

Serial Number

2264919 filed on 21st Jun 2023

MED-OLIGO

Trademark usage description

accounting; administrative management of hospitals; advertising agencies; business merchandising display services; commercial assistance in business m Read More

Classification Information


Class [035]
Accounting; administrative management of hospitals; advertising agencies; business merchandising display services; commercial assistance in business management; export and import agencies; mail order services in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; mediation and conclusion of commercial transactions for others; personnel management consultation; planning concerning business management, namely, searching for partners for amalgamations and business take-overs as well as for business establishments


Classification kind code

12

Class [042]
Design and development of virtual reality software; graphic art design; industrial design; interior design; material testing services; medical research; medical research laboratory services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; software as a service (SaaS) provider in the field of providing customer relations management


Classification kind code

12

Mark Details


Serial Number

2264919

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 30th Oct 2024
Advertised
Submitted for opposition 26
on 02th Oct 2024
Approved
Submitted for opposition 27
on 02th Oct 2024
Approval Notice Sent
Submitted for opposition 22
on 23rd Sep 2024
Search Recorded
Submitted for opposition 30
on 21st Jun 2023
Filed
Submitted for opposition 1
on 21st Jun 2023
Created
Submitted for opposition 31
on 21st Jun 2023
Formalized